Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:38 PM
Ignite Modification Date:
2025-12-24 @ 2:38 PM
NCT ID:
NCT07290959
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (age \>50 years) with multiple AK located on the scalp (at least 5 Olsen grade I or II AK in two symmetrical areas) and diagnosed according to their typical clinical dermoscopic appearance
* Subject must be able to understand and be willing to adhere to all protocol requirements and voluntarily sign and date an informed consent
Exclusion Criteria:
* previous treatment for AK within 6 months;
* status of congenital, infectious, or iatrogenic immunodepression;
* known cutaneous photosensitivity;
* known hypersensitivity to any ingredient of Metvix® 160 135 mg/g cream (Galderma SA, Lausanne, Switzerland).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT07290959
Study Brief:
Protocol Section:
NCT07290959